Related Experiment Video
Updated: Dec 5, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
Published on: October 5, 2020
Role of RIN1 on telomerase activity driven by EGF-Ras mediated signaling in breast cancer
W Zhang1, M L Veisaga2, M A Barbieri3
1Biochemistry PhD Program, Florida International University, 11220 SW 8th Street, Miami, FL, 33199, USA.
Abstract:
Epidermal growth factor (EGF)-receptor regulates several downstream signaling pathways upon EGF stimulation that involves cell proliferation, migration and invasion. Internalized EGF-receptor is either recycled or degraded, which fate is regulated in part by Ras interference 1 (RIN1). In this study, we tested the hypothesis that RIN1, a Ras effector protein and Rab5 guanine nucleotide exchange factor, controls several signaling molecules leading to the modulation of the telomerase activity; thus, allowing proper cell proliferation. We report that expression of RIN1 completely blocked proliferation of MCF-12 A and MCF-7 cells, while partially inhibited proliferation of MDA-MB-231 cells upon EGF stimulation. Furthermore, expression of the C-terminal region of RIN1 selectively plays a critical role in the inhibition of the proliferation of MDA-MB-231 cells. However, this inhibitory effect was specifically affected by the independent expression of RIN1:Vsp9 and RIN1:RA domains. Additionally, endogenous level of expression of RIN1 was decreased in metastatic MDA-MB-231 cells as compared with non-tumorigenic MCF-12 A cells. We observed that expression of RIN1:R94A mutant blocked the proliferation of MDA-MB-231 cells, while expression of RIN1:Y561F and RIN1:R629A mutants completely reversed the inhibitory effect of RIN1:WT. Consistent with our observations, we found that expression of RIN1:WT in MDA-MB-231 cells diminished both protein kinase B (AKT) and extracellular-signal-regulated kinase 1/2 (ERK1/2) activities while p38 mitogen-activated protein kinases (p38 MAPK) and stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) were unaffected, but it produced downregulation of cellular-myelocytomatosis (c-Myc), erythroblast transformation specific (Ets2) and signal transducer and activator of transcription 3 (Stat3) activities. Inversely, expression of high-mobility group box 1 (HMBG1) was inhibited whereas expression of forkhead box transcription factor 1 (FOXO1) was increased in cells expressing RIN1. Interestingly, expression of RIN1 blocked telomerase activity and human telomerase reverse transcriptase (hTERT) expression, which correlated with the downregulations of c-Myc, Ets-2 and Stat3 activation. Taken together these findings indicate that RIN1 is a critical player in the modulation of the telomerase activity as well as hTERT expression in MDA-MB-231 cells upon EGF stimulation.
Insights
Ras interference 1 (RIN1) regulates cell proliferation by modulating telomerase activity and human telomerase reverse transcriptase (hTERT) expression. RIN1 expression inhibits proliferation and blocks telomerase activity in cancer cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Epidermal growth factor receptor (EGFR) signaling drives cell proliferation, migration, and invasion.
- Ras interference 1 (RIN1) is a Ras effector protein and Rab5 GEF that influences EGFR trafficking.
- The role of RIN1 in modulating downstream signaling and telomerase activity remains to be fully elucidated.
Purpose of the Study:
- To investigate the hypothesis that RIN1 modulates telomerase activity and influences cell proliferation.
- To determine the effect of RIN1 expression on cancer cell proliferation and key signaling pathways.
- To identify specific RIN1 domains and mutants involved in proliferation inhibition.
Main Methods:
- Expression of wild-type (WT) RIN1 and its mutants in MCF-12A, MCF-7, and MDA-MB-231 cell lines.
- Assessment of cell proliferation using EGF stimulation.
- Analysis of signaling pathway activation (AKT, ERK1/2, p38 MAPK, JNK) and transcription factor activity (c-Myc, Ets2, Stat3, HMBG1, FOXO1).
- Measurement of telomerase activity and hTERT expression.
Main Results:
- RIN1 expression completely blocked MCF-12A and MCF-7 cell proliferation, and partially inhibited MDA-MB-231 cell proliferation upon EGF stimulation.
- The C-terminal region of RIN1, specifically the Vsp9 and RA domains, is critical for proliferation inhibition in MDA-MB-231 cells.
- Endogenous RIN1 levels were lower in metastatic MDA-MB-231 cells compared to non-tumorigenic MCF-12A cells.
- RIN1 expression diminished AKT and ERK1/2 activity, downregulated c-Myc, Ets2, and Stat3, and increased FOXO1.
- RIN1 expression blocked telomerase activity and hTERT expression, correlating with reduced c-Myc, Ets2, and Stat3 activation.
Conclusions:
- RIN1 plays a critical role in modulating telomerase activity and hTERT expression in MDA-MB-231 cells.
- RIN1 acts as a negative regulator of proliferation in cancer cells by affecting key signaling pathways and transcription factors.
- RIN1's influence on telomerase activity suggests its potential as a therapeutic target in cancer treatment.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a...
Mitogens and the Cell Cycle
Telomeres and Telomerase
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

